S5 - E13.3 - Practical Challenges In Patient Care: Role Of GLP-1s And Scanning
Send us Fan Mail This conversation focuses on what happens after or around patient screening, addressing the challenges caused by using GLP-1s and dual incretin agonists to treat concomitant condition...
4 Touko 202412min
S5 - E13.2 - Global Fatty Liver Day 2024 And The Rationale Behind "Act Now. Get Screened."
Send us Fan Mail This conversation centers around the Global Fatty Liver Day 2024 theme and the rationale behind focusing on screening. It starts with Jeff describing how much has changed in MASLD in...
4 Touko 202412min
S5 - E13.1 - Remembering SurfingMASH Co-Founder Stephen Harrison
Send us Fan Mail On April 23, the global MASLD community lost one of its giants when SurfingMASH Co-founder Stephen Harrison passed away unexpectedly. Co-hosts Louise Campbell and Roger Green and gues...
4 Touko 202410min
S5 - E13 - Previewing Global Fatty Liver Day 2024
Send us Fan Mail Fatty Liver Alliance Founder and President Mike Betel and Global Liver Institute Vice President for Liver Programs Jeff McIntyre join Louise Campbell and Roger Green to preview the pr...
2 Touko 20241h 2min
S5 - E12.6 - From The Vault: More Different Roles For NITs In MASH
Send us Fan Mail One theme in this week's episode involves different ways to use NITs in drug development and assessing the value of older drugs in MASH. This conversation, from our review of last Sep...
28 Huhti 202412min
S5 - E12.5 - MASH Drug Development: Combining With Old Drugs And Shortening Time To Approval
Send us Fan Mail This wrap-up conversation about MASH Drug Development covers two issues: combination therapies with old drugs and using NITs to speed and smooth the path to approval. Louise Campbell...
28 Huhti 202411min
S5 - E12.4 - MASH Drug Development: Implications Of Concomitant Metabolic Therapy Use
Send us Fan Mail This conversation starts by focusing on the impact of concomitant metabolic therapies in MASH drug development and patient treatment and then moves on to explore some major implicatio...
28 Huhti 202413min
S5 - E15.3 - MASH Drug Development: Improvement Since 2020 And Issues That Remain
Send us Fan Mail This conversation includes two sections: one optimizing efficacy endpoints to reflect clinical practice and a second looking back at what has improved in MASH drug development since 2...
27 Huhti 202411min
